Cardinal Health surges as specialty pharma and GLP-1 demand drive guidance raise
Compartilhar
Cardinal Health (NYSE:CAH) delivered a blowout second quarter on Thursday, significantly raising its full-year outlook as the drug wholesaler cashes in on robust demand for specialty therapeutics and high-margin GLP-1 medications.
